These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26947764)

  • 1. Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats.
    Kim JH; Lee YH; Lim BJ; Jeong HJ; Kim PK; Shin JI
    Sci Rep; 2016 Mar; 6():22374. PubMed ID: 26947764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.
    Li C; Sun BK; Lim SW; Song JC; Kang SW; Kim YS; Kang DH; Cha JH; Kim J; Yang CW
    Transplantation; 2005 Jun; 79(11):1522-9. PubMed ID: 15940041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats.
    Endo A; Someya T; Nakagawa M; Murano Y; Sakuraya K; Hara S; Fujinaga S; Ohtomo Y; Murakami H; Shimizu T
    Pediatr Res; 2014 Jan; 75(1-1):38-44. PubMed ID: 24121426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney.
    Yang CW; Ahn HJ; Kim WY; Shin MJ; Kim SK; Park JH; Kim YO; Kim YS; Kim J; Bang BK
    Kidney Int; 2001 Sep; 60(3):847-57. PubMed ID: 11532080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
    Hara S; Umino D; Someya T; Fujinaga S; Ohtomo Y; Murakami H; Shimizu T
    Pediatr Res; 2009 Nov; 66(5):524-7. PubMed ID: 19668109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity.
    Sun BK; Li C; Lim SW; Choi BS; Lee SH; Kim IS; Kim YS; Bang BK; Yang CW
    Nephron Exp Nephrol; 2005; 99(1):e9-16. PubMed ID: 15637465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast attenuates chronic cyclosporine nephrotoxicity in rats.
    Tao Y; Hu L; Li S; Bai Y; Liu Q; Jin Y; Wei D; Luo Z
    Transplant Proc; 2009 Dec; 41(10):4373-5. PubMed ID: 20005402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity.
    Li C; Yang CW; Ahn HJ; Kim WY; Park CW; Park JH; Cha JH; Kim J; Kim YS; Bang BK
    Nephron; 2002 Oct; 92(2):422-30. PubMed ID: 12218323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
    Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS; Yi H; Bennett WM; Andoh TF
    Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
    Li C; Yang CW; Kim WY; Jung JY; Cha JH; Kim YS; Kim J; Bennett WM; Bang BK
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F389-98. PubMed ID: 12529276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
    Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
    Sun QL; Li M; Rui HL; Chen YP
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclosporine in osteopontin null mice.
    Mazzali M; Hughes J; Dantas M; Liaw L; Steitz S; Alpers CE; Pichler RH; Lan HY; Giachelli CM; Shankland SJ; Couser WG; Johnson RJ
    Kidney Int; 2002 Jul; 62(1):78-85. PubMed ID: 12081566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
    J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats.
    Yang CW; Kim YS; Kim J; Kim YO; Min SY; Choi EJ; Bang BK
    Exp Nephrol; 1998; 6(1):50-6. PubMed ID: 9523173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.
    Shihab FS; Bennett WM; Tanner AM; Andoh TF
    Kidney Int; 1997 Sep; 52(3):660-73. PubMed ID: 9291185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
    Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.